Metraipolis › archive › dc_38af24fdf9db

Hemorrhagic Complications in Patients with Atrial Fibrillation Treated with Novel Oral Anticoagulants: Results from the CRAFT Study — Europe PMC PMID:41517478

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41517478
DOI
10.3390/jcm15010229
License (as archived)
solo-consultazione
Archived
2026-11-07T09:22:38.872Z
SHA-256 of the archived text
1019f1c55b80e8ba18b1a6974fa439cae632065117bc89b61548616f6b576608
Stable URL of this page
https://metraipolis.com/documento/dc_38af24fdf9db

How to cite

Hemorrhagic Complications in Patients with Atrial Fibrillation Treated with Novel Oral Anticoagulants: Results from the CRAFT Study — Europe PMC PMID:41517478 — Europe PMC (en), https://europepmc.org/article/MED/41517478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38af24fdf9db (Metraipolis archive dc_38af24fdf9db, sha256 1019f1c55b80e8ba18b1a6974fa439cae632065117bc89b61548616f6b576608)
BibTeX
@misc{dc38af24fdf9db,
  title = {Hemorrhagic Complications in Patients with Atrial Fibrillation Treated with Novel Oral Anticoagulants: Results from the CRAFT Study — Europe PMC PMID:41517478},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41517478},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38af24fdf9db; sha256 1019f1c55b80e8ba18b1a6974fa439cae632065117bc89b61548616f6b576608},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41517478. Agents can read the archived copy with the MCP tool read_document.